Director

Ann D. Rhoads

Director; Audit Committee Chair and Member of the Nominating and Corporate Governance Committee·Globus Medical Inc.

About

Ann D. Rhoads has served on the Globus Medical Board of Directors since July 2011 and is the Chairperson of the Board's Audit Committee and a member of its Nominating and Corporate Governance Committee. Her experience as chief financial officer of publicly traded biotechnology and pharmaceutical companies brings valuable financial skills and expertise to the Board.

Ms. Rhoads most recently served as the Chief Financial Officer of Forty Seven, Inc. (NASDAQ: FTSV), a clinical-stage biotechnology company, from March 2018 to April 2020. Previously, she was Executive Vice President and Chief Financial Officer of Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company, from March 2010 through January 2017. From 2000 through the end of 2009, she served as Chief Financial Officer of Premier, Inc., a healthcare supply management company.

Ms. Rhoads holds a B.S. in finance from the University of Arkansas and an M.B.A. from Harvard Business School. She also serves on the board of directors of Quidel Corporation (NASDAQ: QDEL).

Since 2011
Tenure 15 yrs

Also at Globus Medical Inc.

DP David C. Paul Chairman of the Board of Directors and Executive Chairman KP Keith W. Pfeil Director, President and Chief Executive Officer DD David D. Davidar Director; Member of the Compensation Committee and Nominating and Corporate Governance Committee DL Daniel T. Lemaitre Director; Member of the Compensation Committee and Audit Committee JT James R. Tobin Director; Nominating and Corporate Governance Committee Chair and Member of the Compensation Committee SZ Stephen T. Zarrilli Director; Member of the Audit Committee

Roles

Organization Role Dates Details
Globus Medical Inc. Director; Audit Committee Chair and Member of the Nominating and Corporate Governance Committee 2011–present Current role
Forty Seven, Inc. Chief Financial Officer 2018–2020 Clinical-stage biotechnology company (NASDAQ: FTSV).
Zogenix, Inc. Executive Vice President and Chief Financial Officer 2010–2017 Pharmaceutical company (NASDAQ: ZGNX).
Premier, Inc. Chief Financial Officer 2000–2009 Healthcare supply management company.

External roles

Organization Role Dates
Quidel Corporation Director None

Related

Company Globus Medical Inc. Company hub Person David C. Paul Chairman of the Board of Directors and Executive Chairman Person Keith W. Pfeil Director, President and Chief Executive Officer Person David D. Davidar Director; Member of the Compensation Committee and Nominating and Corporate Governance Committee Person Daniel T. Lemaitre Director; Member of the Compensation Committee and Audit Committee Person James R. Tobin Director; Nominating and Corporate Governance Committee Chair and Member of the Compensation Committee Person Stephen T. Zarrilli Director; Member of the Audit Committee Person Robert A. Douglas Director; Member of the Audit Committee Person Leslie V. Norwalk, Esq. Director; Member of the Audit Committee Person Daniel J. Wolterman Director; Member of the Compensation Committee Person Kelly G. Huller Executive Vice President, General Counsel and Corporate Secretary Person Kyle R. Kline Senior Vice President, Chief Financial Officer Person Daniel T. Scavilla Former President and Chief Executive Officer Deal Globus Medical Alphatec S International Business 2016 Deal page Deal Globus Medical Branch Medical 2015 Deal page Deal Globus Medical Nemaris 2018 Deal page
Source: Globus Medical Inc. SEC filings and official company website

See how VectorShift works for your firm

Request Demo